{{medical}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458438185
| IUPAC_name = 3,5,3',5'-Tetraiodo-L-thyronine
| image = Levothyroxine-2D-skeletal.png
| image2 = Levotiroxina3D.png

<!--Clinical data-->
| tradename = Euthyrox among others, Synthroid, Thyrax
| Drugs.com = {{drugs.com|monograph|levothyroxine-sodium}}
| MedlinePlus = a682461
| pregnancy_AU =  
| pregnancy_US = A
| pregnancy_category =  
| legal_status = RX
| routes_of_administration = 口服、靜脈注射

<!--Pharmacokinetic data-->
| bioavailability = ~100%
| metabolism = 主要由肝、腎、大腦及肌肉
| elimination_half-life = 約7天（[[甲狀腺功能亢進|甲狀腺功能亢進]]時需3-4天，[[甲狀腺機能低下症|甲狀腺機能低下]]時需9-10天）
| excretion = 糞便及尿液

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 51-48-9
| CAS_number2_Ref = {{cascite|correct|CAS}}
| CAS_number2 = 6106-07-6 
| CAS_supplemental2 = <small>（左旋甲狀腺素鈉水合物）</small>
| ATC_prefix = H03
| ATC_suffix = AA01
| PubChem = 5819
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = APRD00235
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5614
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Q51BO43MG4
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 18332
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1624

<!--Chemical data-->
| C=15 | H=11 | I=4 | N=1 | O=4 
| molecular_weight = 776.87
| smiles = c1c(cc(c(c1I)Oc2cc(c(c(c2)I)O)I)I)C[C@@H](C(=O)O)N
| InChI = 1/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1
| InChIKey = XUIIKFGFIJCVMT-LBPRGKRZBS
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XUIIKFGFIJCVMT-LBPRGKRZSA-N
| synonyms = <small>''O''-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine</small>
}}

'''左旋甲狀腺素鈉'''是左旋甲狀腺素的鈉鹽。

'''左旋甲狀腺素'''（Levothyroxine），也叫 '''合成[[甲狀腺素|T<sub>4</sub>]]'''或'3,5,3',5'-四碘-L-甲狀腺素是[[甲狀腺素|甲狀腺素]]（甲狀腺激素）的合成形式，用于患有[[甲狀腺|甲狀腺]]疾患的患者的激素替代治療。天然的甲狀腺激素與該藥物制劑中的一樣在化學結構上是[[手性|手性]]的-L-構型。右旋甲狀腺素曾被作為抗膽固醇藥物進行研究。但因為對心臟的副作用而被取消。

== 醫療用途 ==
左旋甲狀腺素典型地用于治療[[甲狀腺機能低下症|甲狀腺機能低下症]]。<ref name="pmid18662921">{{cite journal |author=Vaidya B, Pearce SH |title=Management of hypothyroidism in adults |journal=BMJ (Clinical research ed.) |volume=337 |issue= |pages=a801 |year=2008 |pmid=18662921 |doi=10.1136/bmj.a801 |url=http://bmj.com/cgi/pmidlookup?view=long&pmid=18662921 |access-date=2011-11-13 |archive-date=2013-01-18 |archive-url=https://archive.is/20130118092638/http://bmj.com/cgi/pmidlookup?view=long&pmid=18662921 |dead-url=no }}</ref>由于左旋甲狀腺素能夠降低[[促甲狀腺激素|促甲狀腺激素]]（thyroid-stimulating hormone，TSH)－一種被認為能誘發[[甲状腺肿|甲状腺肿]]的激素，所以，人們也用左旋甲狀腺素治療甲狀腺腫。<ref name="pmid16507633">{{cite journal |author=Svensson J, Ericsson UB, Nilsson P, ''et al.'' |title=Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis |journal=The Journal of clinical endocrinology and metabolism |volume=91 |issue=5 |pages=1729–34 |pmid=16507633 |doi=10.1210/jc.2005-2400 |url=http://jcem.endojournals.org/cgi/pmidlookup?view=long&pmid=16507633|date=May 2006}}</ref><ref name=Dietlein_2007>{{Cite journal
 | last1 = Dietlein
 | first1 = M
 | last2 = Wegscheider
 | first2 = K
 | last3 = Vaupel
 | first3 = R
 | last4 = Schmidt
 | first4 = M
 | last5 = Schicha
 | first5 = H
 | title = Management of multinodular goiter in Germany (Papillon 2005): do the approaches of thyroid specialists and primary care practitioners differ?
 | journal = Nuklearmedizin. Nuclear medicine
 | volume = 46
 | issue = 3
 | pages = 65–75
 | year = 2007
 | pmid = 17549317
}}</ref>

==不良作用==
確定劑量時，必須將劑量仔細控制在以獲得促甲狀腺激素（TSH）的水平在正常參考值內。長期將TSH值抑制在正常值之下將會頻繁引起對心臟的副作用，同時，還會降低骨無機質密度（人們已經熟知，TSH水平過高也會引起[[骨質疏松症|骨質疏松症]]。）<ref name=Frilling_2004>{{Cite journal
 | last1 = Frilling
 | first1 = A
 | last2 = Liu
 | first2 = C
 | last3 = Weber
 | first3 = F
 | title = Benign multinodular goiter
 | journal = Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society
 | volume = 93
 | issue = 4
 | pages = 278–81
 | year = 2004
 | pmid = 15658668
}}</ref>

給患者處方過劑量的左旋甲狀腺素可能會出現假性的[[甲狀腺機能亢進|甲狀腺機能亢進]]的征象和症狀。<ref name="RxList">{{cite web |url=http://www.rxlist.com/synthroid-drug.htm |title=Synthroid (Levothyroxine Sodium) Drug Information: Uses, Side Effects, Drug Interactions and Warnings |publisher=RxList |accessdate=2010-07-18 |archive-date=2010-05-11 |archive-url=https://web.archive.org/web/20100511145303/http://www.rxlist.com/synthroid-drug.htm |dead-url=no }}</ref>超劑量的左旋甲狀腺激素會引起心悸、腹痛、惡心、焦慮、降神錯亂、激動、失眠、消瘦、和食欲增加。<ref name=Toxicity/>對該藥物的過敏反應特點包括以下症狀：呼吸困難、氣短、或面部和舌頭水腫。急性過量會引起發燒、低血糖、心衰、昏迷、和隐匿性肾上腺机能不全。 

急性大量的過量會威脅生命；需給予對症和支持性治療。治療急性大量過量需使用[[β-受體阻滯劑|β-受體阻滯劑]]，以增強擬交感神經活性。<ref name="RxList"/>

在口服藥物后，超劑量效應會在6小時到11天期間出現。<ref name=Toxicity>{{cite web |url= http://www.emedicine.com/emerg/TOPIC800.HTM |title= Toxicity, Thyroid Hormone |publisher= WebMd |author= Irizarry, Lisandro |date= 2010-04-23 |accessdate= 2010-10-31 |archive-date= 2008-10-14 |archive-url= https://web.archive.org/web/20081014025341/http://www.emedicine.com/emerg/TOPIC800.HTM |dead-url= no }}</ref>

===相互作用===
食物和其他物質會干擾替代性甲狀腺素的吸收。服用甲狀腺素4小時內應避免服用補充鈣或鐵的藥物，<ref>Ruth H. Michel, Patricia J. Neafsey, Laura Cox Dzurec: Self Medication Practices among Patients taking Levothyroxine. The Internet Journal of Advanced Nursing Practice. 2004. Volume 6 Number 2</ref>，并且，在用藥3小時內避免使用黃豆制品，因為，這些東西會減少藥物的吸收。葡萄柚汁會延緩左旋甲狀腺素的吸收，但是，人們確信它對該藥物的生物利用度沒有顯著的影響。<ref name="pmid16120075">{{cite journal |author=Lilja JJ, Laitinen K, Neuvonen PJ |title=Effects of grapefruit juice on the absorption of levothyroxine |journal=Br J Clin Pharmacol |volume=60 |issue=3 |pages=337–41 |pmid=16120075 |pmc=1884777 |doi=10.1111/j.1365-2125.2005.02433.x |url=https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2005-09_60_3/page/337|date=September 2005}}</ref> 其他減少該藥物吸收的物質是含鋁或鎂的抗酸藥物、消泡凈（simethicone）、或硫糖鋁（sucralfate）、消胆胺（cholestyramine）、降脂樹脂II號（colestipol）、凱鉀力寧散（Kayexalate）。一項以八名婦女為受試者的研究發現咖啡干擾左旋甲狀腺素的腸道吸收，儘管，其干擾水平低于食用糠麩。<ref name="Benvenga">{{cite journal|last=Benvenga|first=Salvatore|coauthors=Bartolone, L.; Pappalardo, M.A.; Russo, A.; Lapa, D.; Giorgianni, G.; Saraceno, G.; Trimarchi, F.|date=March 2008|title=Altered Intestinal Absorption of L-Thyroxine Caused by Coffee|journal=Thyroid|publisher=Mary Ann Liebert, Inc.|location=New York|volume=18|issue=3|pages=293–301|pmid=18341376|doi=10.1089/thy.2007.0222|url=http://www.ncbi.nlm.nih.gov/pubmed/18341376?dopt=Citation|accessdate=2009-05-16|archive-date=2018-09-20|archive-url=https://web.archive.org/web/20180920132809/https://www.ncbi.nlm.nih.gov/pubmed/18341376?dopt=Citation|dead-url=no}}</ref>不同的物質會引起其他严重的不良反应。氯胺酮 （Ketamine）會引起高血壓和心動過速，而三環類和四環類抗抑郁藥會增加其毒性。另一方面，鋰會通過影響甲狀腺本身碘的代謝，以及抑制合成的左旋甲狀腺素，從而引起甲狀腺功能亢進（但更多情況是甲狀腺功能減退）。

==劑量==
[[File:007815180lg_Generic_Levothyroxine.jpg|thumb]]

劑量因年齡組和患者資深狀況、體重、對藥物和食物的順從性而異。有必要定期觀察和調整劑量。左旋甲狀腺素應在飯前大約半小時到一小時空腹服用。<ref name="RxList"/>

==商品名==

該藥物常見的商品名包括：歐洲的：Thyrax, Euthyrox（中文名：优甲乐）, '''Levaxin''', '''L-thyroxine''', '''Eltroxin''' 和 '''Thyrax Duotab'''；北美的：'''Thyrox''' in South Asia; '''Eutirox''', '''Tirosint''', '''Levoxyl''' and '''Synthroid'''；中国大陆的：“泽宁”“尤仙”等。同時，還有一些無商品名產品。

==參考文獻==
{{Reflist|2}}

==外部連結==
* [http://medlibrary.org/drugs/thyroid/euthyrox.html Detailed Euthyrox (Levothroid/Levothyroxine) Consumer Information: Uses, Precautions, Side Effects]
* [http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Levothyroxine U.S. National Library of Medicine: Drug Information Portal - Levothyroxine] {{Wayback|url=http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Levothyroxine |date=20160304191322 }} 

[[Category:激素剂|Category:激素剂]]
[[Category:碘化酪氨酸衍生物|Category:碘化酪氨酸衍生物]]